Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693227013 | Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693229011 | Fluocinolone acetonide 62.5 microgram/g cutaneous ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4579911000052111 | fluocinolonacetonid 62,5 mikrogram/gram, kutan salva | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Is a | Product containing fluocinolone (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Is a | Fluocinolone acetonide topical preparation | false | Inferred relationship | Some | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Fluocinolone acetonide (substance) | false | Inferred relationship | Some | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Adrenal hormone | false | Inferred relationship | Some | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has active ingredient | binjurehormonmedel | false | Inferred relationship | Some | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | kutan och/eller transdermal läkemedelsform | false | Inferred relationship | Some | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Is a | fluocinolon för lokalt bruk | false | Inferred relationship | Some | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | Cutaneous ointment | true | Inferred relationship | Some | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | har täljarvärde för koncentrationsstyrka | 62,5 | false | Inferred relationship | Some | 1 | |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has basis of strength substance (attribute) | Fluocinolone acetonide (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has precise active ingredient | Fluocinolone acetonide (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Is a | Product containing only fluocinolone in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Is a | Product containing glucocorticoid (product) | false | Inferred relationship | Some | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Is a | Product containing fluorinated corticosteroid (product) | false | Inferred relationship | Some | ||
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | Is a | Product manufactured as cutaneous dose form (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR